Sort   by:  
 Page size 
MetabolomicsInvestigation of cross-platform analytical precision in NMR and UPLC-MS based metabolic-phenotyping
Dataset of six samples of pooled human urine, aliquoted, and independently prepared and aquired by NMR spectroscopy, and UPLC-MS. Each source sample is seperatly prepared and assayed thirteen times. A pooled QC sample and independent external reference of a compariable matrix is also aquired to assi...
2018-08-31 | MTBLS694 | MetaboLights
UnknownEarly intervention with Bifidobacterium lactis NCC2818 modulates the host-microbe interface independent of the sustained changes induced by the neonatal environment.
Not available
S-EPMC5509696 | biostudies-literature
UnknownElectrohydrodynamic Vortex Imaging: A New Tool for Understanding Mass Transfer in Surface-Based Biosensors.
Not available
S-EPMC12514429 | biostudies-literature
UnknownSystemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes.
Not available
S-EPMC2583082 | biostudies-literature
MetabolomicsFecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights
UnknownNeonatal environment exerts a sustained influence on the development of the intestinal microbiota and metabolic phenotype.
Not available
S-EPMC4681865 | biostudies-literature
UnknownDetection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy.
Not available
S-EPMC6688492 | biostudies-literature
UnknownChemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects.
Not available
S-EPMC5528498 | biostudies-literature
UnknownNeoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.
Not available
S-EPMC11252284 | biostudies-literature
UnknownMetabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.
Not available
S-EPMC1567909 | biostudies-literature
Sort   by:  
 Page size